% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share
(X) D. Taxation ภาษี (X) E. Dividends and Paying Agents เงินปนผลและตัวแทนชําระเงินของผูออกหลักทรัพย (X) G. Statement by Experts ขอความโดยผูเชีย่วชาญ (X) H. Sign offs or consents from persons
million, a 9 .74% or Baht 37.72 million growing up from the same period of previous year. The hospital revenues grew by 10.04% mainly due to the increase in medical service income from Social Security
Acquisition of Assets and the Connected Transaction 2. Information Memorandum regarding the offering of the newly issued ordinary shares to specific investors (Private Placement) 3. Capital Increase Report Form
Medical Business Pcl., (CMR) amount Baht 872.11 million. comparing at the same period in 2016 representing 8.11% increase. Income from medical treatments in the separate financial went up 4.19% due to the
higher than last year at 33%, an increase of 38% or Baht 58.34 million from the previous year. Total selling and administrative expenses for Q2/2019 were at Baht 217.63 million, slightly up Baht 4.31
preparations for economic, social and environmental changes, which will lead to the increase in opportunities and competitiveness. The Company may provide a brief description as deemed appropriate. In addition
lead to the increase in opportunities and competitiveness. The Company may provide a brief description as deemed appropriate. In addition, disclose the expenses spent on such research and development
. Which the company will sign the share purchase agreement on July 24, 2019. Details of such items appear in Attachment 1: Information Memorandum Concerning the Disposition of Assets Please be informed